Orobac 200 Tablet

Cefditoren
200 mg
Incepta Pharmaceuticals Ltd.
Pack size 8's Pack
Dispensing mode
Source
Agent
Retail Price 150.00 AED

Indications

Orobac 200 Tablet is used for: Pharyngitis, Community-acquired pneumonia, Susceptible infections, Tonsillitis, Soft tissue infections, Respiratory tract infections, Acute Exacerbations of Chronic bronchitis

Adult Dose

Oral Community-acquired pneumonia Adult: 400 mg bid for 14 days. Acute bacterial exacerbation of chronic bronchitis Adult: 400 mg bid for 10 days. Pharyngitis ; Tonsillitis; Uncomplicated skin and skin structure infections Adult: 200 mg bid for 10 days.

Child Dose

<12 years old: Safety & efficacy not established >12 years old: As in adults

Renal Dose

Renal Impairment CrCl 30-49 mL/minute/1.73 sq. meter: No more than 200 mg PO q12hr CrCl <30 mL/minute/1.73/sq.meter: 200 mg PO qDay End-stage: Dosing not established

Administration

Should be taken with food.

Contra Indications

Hypersensitivity to Cefditoren, other cephalosporins; or milk proteins. Carnitine deficiency.

Precautions

May cause diarrhea, nausea, and vaginal moniliasis (yeast infection); pseudomembranous colitis may occur; clinical manifestations of carnitine deficiency may occur with prolonged use; prolonged use may result in emergence and overgrowth of resistant organisms; caution in breastfeeding

Pregnancy-Lactation

Pregnancy Category: B Lactation: excretion in milk unknown; use with caution

Interactions

Reduced oral bioavailability when coadministered with antacids or H2-receptor antagonists. Probenecid may increase plasma concentration and prolong the half-life of Cefditoren. May enhance the anticoagulant effect of vitamin K antagonists (e.g. warfarin). Contraindicated (0) Serious (3) BCG vaccine live cholera vaccine microbiota oral

Adverse Effects

Side effects of Cefditoren : >10% Diarrhea (11-15%) 1-10% Nausea (4-6%),Headache (2-3%),Abdominal pain (2%),Dyspepsia (1-2%),Vomiting (1%) <1% Bacterial/fungal superinfection,C. difficile colitis,Hypersensitivity,Increased bleeding time,Stevens-Johnson syndrome,Vaginal moniliasis Potentially Fatal: Hypersensitivity, anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis.

Mechanism of Action

Cefditoren is a third generation cephalosporin used for treatment of susceptible infections caused by gram-positive and gram-negative bacteria. It inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs).

Note

Orobac 200 200 mg Tablet manufactured by Incepta Pharmaceuticals Ltd.. Its generic name is Cefditoren. Orobac 200 is availble in Bangladesh. Farmaco BD drug index information on Orobac 200 Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Cefditoren :